Xing C - Search Results

1

The association of frequent allelic loss on 17p13.1 with early metastatic recurrence of hepatocellular carcinoma after liver transplantation.

Zhou L, Zhou W, Wu L, Yu X, Xing C, Zheng S. Zhou L, et al. Among authors: xing c. J Surg Oncol. 2010 Dec 1;102(7):802-8. doi: 10.1002/jso.21743. J Surg Oncol. 2010. PMID: 20886556 Clinical Trial.

2

O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.

Zhu Q, Zhou L, Yang Z, Lai M, Xie H, Wu L, Xing C, Zhang F, Zheng S. Zhu Q, et al. Among authors: xing c. Med Oncol. 2012 Jun;29(2):985-93. doi: 10.1007/s12032-011-9912-1. Epub 2011 Apr 3. Med Oncol. 2012. PMID: 21461968

3

Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.

Xing C, Xie H, Zhou L, Zhou W, Zhang W, Ding S, Wei B, Yu X, Su R, Zheng S. Xing C, et al. Biochem Biophys Res Commun. 2012 Mar 30;420(1):29-35. doi: 10.1016/j.bbrc.2012.02.107. Epub 2012 Feb 27. Biochem Biophys Res Commun. 2012. PMID: 22390936

4

microRNA-200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6.

Xiao F, Zhang W, Zhou L, Xie H, Xing C, Ding S, Chen K, Zheng S. Xiao F, et al. Among authors: xing c. Oncol Rep. 2013 Nov;30(5):2203-10. doi: 10.3892/or.2013.2715. Epub 2013 Sep 4. Oncol Rep. 2013. PMID: 24009066

5

Oncogenic role of microRNA-423-5p in hepatocellular carcinoma.

Wu LM, Ji JS, Yang Z, Xing CY, Pan TT, Xie HY, Zhang F, Zhuang L, Zhou L, Zheng SS. Wu LM, et al. Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):613-8. doi: 10.1016/s1499-3872(15)60038-8. Hepatobiliary Pancreat Dis Int. 2015. PMID: 26663009

6

Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma.

Xie H, Xing C, Wei B, Xu X, Wu L, Wu J, Chen L, Cao G, Chen H, Meng X, Yin S, Zhou L, Zheng S. Xie H, et al. Among authors: xing c. Tumour Biol. 2015 Nov;36(11):8881-6. doi: 10.1007/s13277-015-3643-4. Epub 2015 Jun 12. Tumour Biol. 2015. PMID: 26069105

7

Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma.

Xing C, Zhou W, Ding S, Xie H, Zhang W, Yang Z, Wei B, Chen K, Su R, Cheng J, Zheng S, Zhou L. Xing C, et al. Mol Cancer Ther. 2013 Jan;12(1):94-103. doi: 10.1158/1535-7163.MCT-12-0672. Epub 2012 Nov 6. Mol Cancer Ther. 2013. PMID: 23136185

8

Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy.

Cheng J, Gao F, Chen X, Wu J, Xing C, Lv Z, Xu W, Xie Q, Wu L, Ye S, Xie H, Zheng S, Zhou L. Cheng J, et al. Among authors: xing c. Mol Carcinog. 2014 Oct;53(10):820-32. doi: 10.1002/mc.22040. Epub 2013 May 9. Mol Carcinog. 2014. PMID: 23661548

9

Induction of an EMT-like transformation and MET in vitro.

Ding S, Zhang W, Xu Z, Xing C, Xie H, Guo H, Chen K, Song P, Gu Y, Xiao F, Zhou L, Zheng S. Ding S, et al. Among authors: xing c. J Transl Med. 2013 Jul 7;11:164. doi: 10.1186/1479-5876-11-164. J Transl Med. 2013. PMID: 23829659 Free PMC article.

10

MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, Cheng J, Zheng S, Zhou L. Xiao F, et al. Among authors: xing c. J Transl Med. 2013 Aug 22;11:195. doi: 10.1186/1479-5876-11-195. J Transl Med. 2013. PMID: 23967867 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,416 results

Search Page

Filters